查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600664

药物委外研发机构服务市场：按类型、研究阶段、治疗领域、分子类型、最终用户 - 2025-2030 年全球预测

Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药物委外研发机构服务市场规模预计为870亿美元，预计2024年将达到963.1亿美元，复合年增长率为10.97%，预计到2030年将达到1803.6亿美元。

在製药、生物技术和医疗设备业，CRO（合约研究委外研发机构）服务透过外包研究服务帮助加速产品开发、降低成本、更有效率地将新产品推向市场发挥重要作用。这些服务包括早期开发、临床试验管理、化验服务、资料管理和监管咨询。日益复杂的法规环境、不断上升的药物开发成本以及并非所有公司都持有内部专业知识的需求推动了对 CRO 服务的需求。 CRO 服务的应用程式跨越研发的各个阶段，为寻求优化资源的公司提供灵活性和扩充性。最终用途产业包括製药公司、生技公司、医疗设备製造商、学术研究机构和政府研究组织。

主要市场统计
基准年[2023] 870亿美元
预测年份 [2024] 963.1亿美元
预测年份 [2030] 1803.6亿美元
复合年增长率（%） 10.97%

该市场受到多种成长要素的影响，包括生物技术的快速发展、对个人化医疗的重视以及製药和生物技术公司研发支出的增加。随着精准医学的兴起，将服务范围扩展到基因组学和生物资讯学等新领域是一个潜在的商机。策略联盟和收购增强了我们的服务能力和地理覆盖范围，提供了显着的竞争优势。挑战包括维护资料安全和监管合规性，这需要大量投资和专业知识，以及成熟新兴企业，这给定价策略和利润率带来压力。也存在一些限制，例如潜在的业务效率低下以及对提供服务的行业经济状况的依赖。

投资的创新领域包括开发先进的资料分析解决方案、利用人工智慧和机器学习增强临床试验技术，以及专注于以患者为中心的方法来提高临床试验的註册率和保留率。 CRO 市场的动态和竞争性质需要不断适应技术进步和不断变化的行业需求。能够利用技术整合并保持敏捷营运模式的公司处于有利地位，可以抓住成长机会，同时降低相关的市场风险。

市场动态：快速发展的委外研发机构市场的关键市场洞察

药品委外研发机构服务市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 加大医药研发投入
    • 生技药品和核子医学的扩展
    • 研究活动中更采用外包服务
  • 市场限制因素
    • 资料管理和完整性问题
  • 市场机会
    • CRO 采用数位化、敏捷製造和研发技术
    • 强调更先进的细胞和基因疗法的新颖临床试验设计和通讯协定
  • 市场挑战
    • 临床研究中的病患招募与保留问题

波特五力：开拓委外研发机构服务市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对药物委外研发机构服务市场的影响

外部宏观环境因素在塑造合约药物委外研发机构服务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药品委外研发机构服务市场的竞争状况

委外研发机构服务市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 药物委外研发机构服务市场供应商绩效评估

FPNV定位矩阵是评估委外研发机构服务市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划药物委外研发机构服务市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对药物委外研发机构服务市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 加大医药研发投入
      • 生技药品和核子医学的扩展
      • 研究活动中越来越多采用外包服务
    • 抑制因素
      • 资料管理和完整性问题
    • 机会
      • CRO引进数位化、敏捷製造/研发技术
      • 专注于更先进的细胞和基因疗法的新临床试验设计和通讯协定
    • 任务
      • 临床研究中的病患招募与保留问题
  • 市场区隔分析
    • 类型：实施临床研究服务以管理临床试验的复杂性和持续时间
    • 实验阶段：需要具有强大真实资料和上市后支援能力的CRO
    • 治疗领域：CRO服务在肿瘤药物开发活动中的一贯优先地位
    • 最终用户：需要学术和研究机构强大的基础研究能力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品委外研发机构服务市场：依类型

  • 临床研究服务
  • 咨询服务
  • 资料管理服务
  • 早期开发服务
    • 化学、製造、管理
    • 发现研究
    • 临床前服务
      • 药物动力学/动态
      • 毒性试验
  • 化验服务
    • 分析测试
      • 批次放行测试
      • 物理特性
      • 原料检测
      • 稳定性测试
    • 生物分析测试

第七章 药品委外研发机构服务市场试行阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第八章依治疗领域分類的药物委外研发机构服务市场

  • 心血管疾病
  • 皮肤科
  • 胃肠道
  • 泌尿系统和女性健康
  • 血液学
  • 免疫疾病
  • 感染疾病
  • 代谢疾病/内分泌学
  • 神经病学
  • 肿瘤学
  • 眼科
  • 精神病学
  • 呼吸系统疾病

第九章按分子类型分類的药物委外研发机构服务市场

  • 细胞和基因治疗疾病
  • 疫苗

第十章 药品委外研发机构服务市场：依最终用户分类

  • 学术机构
  • 医疗设备公司
  • 製药和生物技术公司

第十一章：美洲药物委外研发机构服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章 亚太地区药物委外研发机构服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲/中东/非洲药品委外研发机构服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Lindas Health 推出“一体化皮肤科 CRO”，彻底改变了皮肤科临床试验
    • Alcent 与 BARDA 建立五年伙伴关係，推动医疗对策的分散临床试验
    • Paleos Healthcare GmbH 与 OCT Clinical GmbH 的策略合併扩大了欧洲的临床研究
    • Vida Clinical Research 透过策略收购欧洲 CRO 加强全球影响力
    • EUROAPI 和 SpiroChem 之间的创新合作彻底改变了药物开发中的 CRO-CDMO 整合
    • Maridose 成立创新型 CRO 团队进行大麻药物开发
    • Julius Clinical Research 获得 Ampersand Capital Partners 的成长投资
    • Everest Clinical Research 宣布收购 August Research
    • PRC Clinical 与 TrialHub 合作提高临床试验效率和患者招募
    • OrganaBio 推出创新的细胞处理和冷冻保存服务以支持分散的临床试验
    • MedRhythms 选择 Curavit 作为慢性中风分散临床试验的合约研究组织 (CRO)
    • 透过与世界各地的临床试验和所有治疗方法的策略伙伴关係关係来创新医疗保健
    • ClinChoice 透过策略收购 CROMSOURCE 扩大全球影响力
    • Avanir 收购 Maxis：加强医疗技术开发和商业化
    • TFS Health Sciences 透过收购 Apple Tree CI Group 拓展视野
  • 战略分析和建议
    • 维达临床研究有限公司

公司名单

  • AccuLab Life Sciences
  • ACTIVA-CRO
  • Advanced Clinical Research Services, LLC
  • BioAgile Therapeutics Pvt. Ltd.
  • Caidya
  • Calian Group Ltd.
  • Celerion, Inc.
  • Charles River Laboratories International, Inc.
  • Clinical Trial Service BV by PCM Trials
  • Cromsource by ClinChoice
  • CTI Clinical Trial & Consulting
  • Distefar del Sur SL
  • Ergomed PLC
  • Firma Clinical Research, LLC
  • Frontage Holdings Corporation
  • Geistek Pharma SL
  • HCL Technologies Limited
  • Icon PLC
  • INQUIS
  • IQVIA Holdings Inc.
  • KCR SA
  • Laboratory Corporation of America Holdings
  • Leon Research, SL
  • Linical Co., Ltd.
  • Medpace Holdings, Inc.
  • Novotech Health Holdings
  • OPIS Srl
  • Oxon Epidemiology, SL
  • Parexel International Corporation
  • Pepgra
  • Pharmaron Beijing Co., Ltd.
  • Pivotal, SLU
  • PPD Inc. by Thermo Fisher Scientific Inc.
  • Prometrika, LLC
  • ProRelix Services LLP
  • PSI CRO AG
  • QualitecFarma SL
  • SGS SA
  • Syncro Clinical Research SRL
  • Syneos Health, Inc.
  • The Emmes Company, LLC
  • Veeda Clinical Research Limited
  • Vial Health Technology, Inc.
  • Worldwide Clinical Trials Holdings Inc.
  • WuXi AppTec Co., Ltd.
  • X7 Research
Product Code: MRR-5012464360F9

The Contract Research Organization Services Market was valued at USD 87.00 billion in 2023, expected to reach USD 96.31 billion in 2024, and is projected to grow at a CAGR of 10.97%, to USD 180.36 billion by 2030.

Contract Research Organization (CRO) services play a critical role in the pharmaceutical, biotechnology, and medical device industries by providing outsourced research services to accelerate product development, reduce costs, and improve the efficiency of getting new products to market. These services encompass early-phase development, clinical trial management, laboratory services, data management, and regulatory consulting, among others. The necessity for CRO services is driven by increasingly complex regulatory environments, the rising costs of drug development, and the need for specialized expertise that not all companies possess in-house. Their application spans various stages of research and development, offering flexibility and scalability to companies looking to optimize their resources. End-use industries include pharmaceuticals, biotechnology firms, and medical device manufacturers, along with academic and government research institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 87.00 billion
Estimated Year [2024] USD 96.31 billion
Forecast Year [2030] USD 180.36 billion
CAGR (%) 10.97%

The market is influenced by several growth factors, such as rapid advancements in biotechnology, a greater emphasis on personalized medicine, and increased R&D expenditure by pharmaceutical and biotechnology companies. Potential opportunities lie in expanding service offerings to include emerging fields like genomics and bioinformatics, which are gaining traction due to the rise of precision medicine. Strategic partnerships and acquisitions can enhance service capabilities and geographical reach, providing significant competitive advantages. Challenges include maintaining data security and regulatory compliance, which require significant investment and expertise, and the intense competition among established and emerging players, which pressures pricing strategies and margins. Limitations also include potential operational inefficiencies and dependence on the economic health of the industries they serve.

Innovation areas ripe for investment include developing advanced data analytics solutions, enhancing clinical trial technologies through AI and machine learning, and focusing on patient-centric approaches that improve enrollment and retention in trials. The nature of the CRO market is dynamic and competitive, necessitating continual adaptation to technological advancements and shifting industry demands. Companies that can leverage technological integration and maintain agile operational models are well-positioned to capture growth opportunities while mitigating associated market risks.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contract Research Organization Services Market

The Contract Research Organization Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing investments in pharmaceutical research and development
    • Growing penetration of biologics and nuclear medicines
    • Rise in adoption of outsourced services for research activities
  • Market Restraints
    • Concerns associated with data management and integrity
  • Market Opportunities
    • Adoption of digitized and agile manufacturing and research development techniques by CROs
    • Emphasis on novel clinical trial designs and protocols for more advanced cell and gene therapy
  • Market Challenges
    • Issues of patient recruitment and retention for clinical research

Porter's Five Forces: A Strategic Tool for Navigating the Contract Research Organization Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contract Research Organization Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contract Research Organization Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contract Research Organization Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contract Research Organization Services Market

A detailed market share analysis in the Contract Research Organization Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contract Research Organization Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contract Research Organization Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Contract Research Organization Services Market

A strategic analysis of the Contract Research Organization Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contract Research Organization Services Market, highlighting leading vendors and their innovative profiles. These include AccuLab Life Sciences, ACTIVA-CRO, Advanced Clinical Research Services, LLC, BioAgile Therapeutics Pvt. Ltd., Caidya, Calian Group Ltd., Celerion, Inc., Charles River Laboratories International, Inc., Clinical Trial Service B.V. by PCM Trials, Cromsource by ClinChoice, CTI Clinical Trial & Consulting, Distefar del Sur SL, Ergomed PLC, Firma Clinical Research, LLC, Frontage Holdings Corporation, Geistek Pharma S.L., HCL Technologies Limited, Icon PLC, INQUIS, IQVIA Holdings Inc., KCR S.A., Laboratory Corporation of America Holdings, Leon Research, S.L., Linical Co., Ltd., Medpace Holdings, Inc., Novotech Health Holdings, OPIS S.r.l., Oxon Epidemiology, S.L., Parexel International Corporation, Pepgra, Pharmaron Beijing Co., Ltd., Pivotal, S.L.U., PPD Inc. by Thermo Fisher Scientific Inc., Prometrika, LLC, ProRelix Services LLP, PSI CRO AG, QualitecFarma S.L., SGS S.A., Syncro Clinical Research SRL, Syneos Health, Inc., The Emmes Company, LLC, Veeda Clinical Research Limited, Vial Health Technology, Inc., Worldwide Clinical Trials Holdings Inc., WuXi AppTec Co., Ltd., and X7 Research.

Market Segmentation & Coverage

This research report categorizes the Contract Research Organization Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Clinical Research Services, Consulting Services, Data Management Services, Early Phase Development Services, and Laboratory Services. The Early Phase Development Services is further studied across Chemistry, Manufacturing & Control, Discovery Studies, and Preclinical Services. The Preclinical Services is further studied across Pharmacokinetics/Pharmacodynamics and Toxicology Testing. The Laboratory Services is further studied across Analytical Testing and Bioanalytical Testing. The Analytical Testing is further studied across Batch Release Testing, Physical Characterization, Raw Material Testing, and Stability Testing.
  • Based on Trial Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.
  • Based on Therapeutic Area, market is studied across Cardiovascular Disease, Dermatology, Gastrointestinal, Genitourinary & Women's Health, Hematology, Immunological Disorders, Infectious Diseases, Metabolic Disorders/Endocrinology, Neurology, Oncology, Ophthalmology, Psychiatry, and Respiratory Disorders.
  • Based on Molecule Type, market is studied across Cell & Gene Therapy Diseases and Vaccines.
  • Based on End-User, market is studied across Academic Institutes, Medical Device Companies, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing investments in pharmaceutical research and development
      • 5.1.1.2. Growing penetration of biologics and nuclear medicines
      • 5.1.1.3. Rise in adoption of outsourced services for research activities
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with data management and integrity
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of digitized and agile manufacturing and research development techniques by CROs
      • 5.1.3.2. Emphasis on novel clinical trial designs and protocols for more advanced cell and gene therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Issues of patient recruitment and retention for clinical research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Adoption of clinical research services to manage the complexity and duration of clinical trials
    • 5.2.2. Trial Phase: Need for CROs with strong capabilities in real-world data and post-market support
    • 5.2.3. Therapeutic Area: Consistent preference for CRO services in oncology drug development activities
    • 5.2.4. End-User: Need for strong foundational research capabilities by academic and research institutions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contract Research Organization Services Market, by Type

  • 6.1. Introduction
  • 6.2. Clinical Research Services
  • 6.3. Consulting Services
  • 6.4. Data Management Services
  • 6.5. Early Phase Development Services
    • 6.5.1. Chemistry, Manufacturing & Control
    • 6.5.2. Discovery Studies
    • 6.5.3. Preclinical Services
      • 6.5.3.1. Pharmacokinetics/Pharmacodynamics
      • 6.5.3.2. Toxicology Testing
  • 6.6. Laboratory Services
    • 6.6.1. Analytical Testing
      • 6.6.1.1. Batch Release Testing
      • 6.6.1.2. Physical Characterization
      • 6.6.1.3. Raw Material Testing
      • 6.6.1.4. Stability Testing
    • 6.6.2. Bioanalytical Testing

7. Contract Research Organization Services Market, by Trial Phase

  • 7.1. Introduction
  • 7.2. Phase I
  • 7.3. Phase II
  • 7.4. Phase III
  • 7.5. Phase IV

8. Contract Research Organization Services Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Disease
  • 8.3. Dermatology
  • 8.4. Gastrointestinal
  • 8.5. Genitourinary & Women's Health
  • 8.6. Hematology
  • 8.7. Immunological Disorders
  • 8.8. Infectious Diseases
  • 8.9. Metabolic Disorders/Endocrinology
  • 8.10. Neurology
  • 8.11. Oncology
  • 8.12. Ophthalmology
  • 8.13. Psychiatry
  • 8.14. Respiratory Disorders

9. Contract Research Organization Services Market, by Molecule Type

  • 9.1. Introduction
  • 9.2. Cell & Gene Therapy Diseases
  • 9.3. Vaccines

10. Contract Research Organization Services Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic Institutes
  • 10.3. Medical Device Companies
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Contract Research Organization Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Contract Research Organization Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Contract Research Organization Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Lindus Health revolutionizes dermatology trials with 'all-in-one dermatology CRO' launch
    • 14.3.2. Allucent secures 5-Year BARDA partnership to advance decentralized clinical trials for medical countermeasures
    • 14.3.3. Strategic merger between palleos healthcare GmbH and OCT Clinical GmbH expands clinical research in Europe
    • 14.3.4. Veeda Clinical Research Bolsters Global Presence with Strategic Acquisition of European CRO, Heads
    • 14.3.5. Innovative Partnership between EUROAPI and SpiroChem Revolutionizes CRO-CDMO Integration for Drug Development
    • 14.3.6. Maridose Launches Innovative CRO Group for Cannabis-Based Drug Development
    • 14.3.7. Julius Clinical Research Receives Growth Investment from Ampersand Capital Partners
    • 14.3.8. Everest Clinical Research Announces the Acquisition of August Research
    • 14.3.9. PRC Clinical and TrialHub Unite to Elevate Clinical Trial Efficiency and Patient Recruitment
    • 14.3.10. OrganaBio Launches Innovative Cell Processing and Cryopreservation Services to Support Decentralized Clinical Trials
    • 14.3.11. MedRhythms Choses Curavit as its Contract Research Organization (CRO) for a Chronic Stroke Decentralized Clinical Trial
    • 14.3.12. Innovating Healthcare through a Strategic Partnership between Worldwide Clinical Trials and Every Cure
    • 14.3.13. ClinChoice Expands Global Reach with Strategic Acquisition of CROMSOURCE
    • 14.3.14. Avania Acquires MAXIS: Enhancing Medtech Development and Commercialization
    • 14.3.15. TFS HealthScience Broadens Its Horizons with Appletree CI Group Acquisition
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Veeda Clinical Research Limited

Companies Mentioned

  • 1. AccuLab Life Sciences
  • 2. ACTIVA-CRO
  • 3. Advanced Clinical Research Services, LLC
  • 4. BioAgile Therapeutics Pvt. Ltd.
  • 5. Caidya
  • 6. Calian Group Ltd.
  • 7. Celerion, Inc.
  • 8. Charles River Laboratories International, Inc.
  • 9. Clinical Trial Service B.V. by PCM Trials
  • 10. Cromsource by ClinChoice
  • 11. CTI Clinical Trial & Consulting
  • 12. Distefar del Sur SL
  • 13. Ergomed PLC
  • 14. Firma Clinical Research, LLC
  • 15. Frontage Holdings Corporation
  • 16. Geistek Pharma S.L.
  • 17. HCL Technologies Limited
  • 18. Icon PLC
  • 19. INQUIS
  • 20. IQVIA Holdings Inc.
  • 21. KCR S.A.
  • 22. Laboratory Corporation of America Holdings
  • 23. Leon Research, S.L.
  • 24. Linical Co., Ltd.
  • 25. Medpace Holdings, Inc.
  • 26. Novotech Health Holdings
  • 27. OPIS S.r.l.
  • 28. Oxon Epidemiology, S.L.
  • 29. Parexel International Corporation
  • 30. Pepgra
  • 31. Pharmaron Beijing Co., Ltd.
  • 32. Pivotal, S.L.U.
  • 33. PPD Inc. by Thermo Fisher Scientific Inc.
  • 34. Prometrika, LLC
  • 35. ProRelix Services LLP
  • 36. PSI CRO AG
  • 37. QualitecFarma S.L.
  • 38. SGS S.A.
  • 39. Syncro Clinical Research SRL
  • 40. Syneos Health, Inc.
  • 41. The Emmes Company, LLC
  • 42. Veeda Clinical Research Limited
  • 43. Vial Health Technology, Inc.
  • 44. Worldwide Clinical Trials Holdings Inc.
  • 45. WuXi AppTec Co., Ltd.
  • 46. X7 Research

LIST OF FIGURES

  • FIGURE 1. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CHEMISTRY, MANUFACTURING & CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DISCOVERY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BATCH RELEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHYSICAL CHARACTERIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RAW MATERIAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CELL & GENE THERAPY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 215. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 222. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 224. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 225. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 226. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 241. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 242. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 243. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 244. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 245. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 250. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 251. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 252. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 253. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 254. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 258. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 259. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 260. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 261. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 262. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 263. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 267. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
  • TABLE 268. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 270. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
  • TABLE 271. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 272. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. GERMANY CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
  • TABLE 276. GERMANY CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLI